FDA — authorised 15 September 2009
- Application: NDA022211
- Marketing authorisation holder: BAUSCH AND LOMB
- Local brand name: ZIRGAN
- Indication: GEL — OPHTHALMIC
- Status: approved
FDA authorised Zirgan on 15 September 2009
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 15 September 2009; FDA has authorised it.
BAUSCH AND LOMB holds the US marketing authorisation.